Effectiveness of Telerehabilitation in Continuity With Outpatient Physiotherapy After Total Hip Replacement.

February 19, 2026 updated by: Istituto Ortopedico Rizzoli

Effectiveness of Telerehabilitation in Continuity With Outpatient Physiotherapy After Total Hip Replacement: Randomized Clinical Trial.

Total arthroplasty (THA) is the treatment of choice for severe osteoarthritis of the hip joint. Following this type of intervention, a multidisciplinary rehabilitation approach allows you to reduce pain and improve the ability to carry out activities of daily living (ADL), but it is not clear what the optimal rehabilitation program is. Recently, the use of telerehabilitation has increased over the years. Specifically, in treatment of patients following THA surgery, telerehabilitation is able to give similar results to the treatment performed in person terms of pain and function. The aim of this study is to verify whether telerehabilitation associated with In-person treatment is comparable in terms of pain, recovery functionality and patient participation and satisfaction, compared to those provided by rehabilitation alone in the presence of patients undergoing THA surgery.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

104

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Italy
    • Italia
      • Bologna, Italia, Italy, 40136
        • Recruiting
        • IRCCS Istituto Ortopedico Rizzoli
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Having undergone total hip replacement surgery (THA)
  • Start outpatient treatment within 7 days of discharge from the Orthopedic Department
  • Age between 50 and 80 years.
  • Continuation of rehabilitation treatments at the IOR Physical Medicine and Rehabilitation service in Argenta.
  • The subjects or any caregivers must be able to use an electronic device (PC, tablet, smartphone).

Exclusion Criteria:

  • patients undergoing revision of previous prosthesis surgery
  • difficulty understanding the Italian language/language barrier
  • unavailability stable wi-fi connection by the patient

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Telerehabilitation

the patients who will be randomized and subjected to the experimental treatment will undergo a physiotherapy treatment with a biweekly frequency which will be started at the same times as the standard group.

After the sixth session, the process will continue through telerehabilitation until the end of outpatient treatment.
Other: Telerehabilitation
the patient will undergo 10 session of tele rehabilitation in continuity with traditional physiotherapy
Active Comparator: traditional physiotherapy
Patients who will be randomized and subjected to standard treatment (usual care at our clinic) will undergo physiotherapy treatment on a bi-weekly basis in person.
Other: Traditional rehabilitation
the patient will undergo 16 session of outpatient physiotherapy rehabilitation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hip disability and Osteoarthritis Outcome score (HOOS)
Time Frame: At baseline (day 0)
The HOOS is a 40-item self-report questionnaire with 5 subscales. A normalized score is calculated for each subscale with 0 indicating extreme symptoms and 100 representing no symptoms.
At baseline (day 0)
Hip disability and Osteoarthritis Outcome score (HOOS)
Time Frame: After 8 weeks
The HOOS is a 40-item self-report questionnaire with 5 subscales. A normalized score is calculated for each subscale with 0 indicating extreme symptoms and 100 representing no symptoms.
After 8 weeks
Hip disability and Osteoarthritis Outcome score (HOOS)
Time Frame: After 12 weeks
The HOOS is a 40-item self-report questionnaire with 5 subscales. A normalized score is calculated for each subscale with 0 indicating extreme symptoms and 100 representing no symptoms.
After 12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Timed Up and GO (TUG)
Time Frame: After 8 weeks
The test measures the time (in seconds) it takes a patient to get up from a chair, walk 3 meters, reverse and sit back in the chair. It can be performed without aids or with the aid usually used by the patient to walk.
After 8 weeks
Timed Up and GO (TUG)
Time Frame: After 12 weeks
The test measures the time (in seconds) it takes a patient to get up from a chair, walk 3 meters, reverse and sit back in the chair. It can be performed without aids or with the aid usually used by the patient to walk.
After 12 weeks
Harris Hip Score (HHS)
Time Frame: After 8 weeks
a multi-disability measurement tool, validated and translated into Italian, composed of a questionnaire and a specific clinical examination which has the aim of evaluating ADL and function in subjects with hip pathology
After 8 weeks
Harris Hip Score (HHS)
Time Frame: After 12 weeks
a multi-disability measurement tool, validated and translated into Italian, composed of a questionnaire and a specific clinical examination which has the aim of evaluating ADL and function in subjects with hip pathology
After 12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Istituto Ortopedico Rizzoli

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 10, 2024

Primary Completion (Estimated)

November 10, 2026

Study Completion (Estimated)

December 10, 2026

Study Registration Dates

First Submitted

January 26, 2024

First Submitted That Met QC Criteria

January 26, 2024

First Posted (Actual)

February 2, 2024

Study Record Updates

Last Update Posted (Actual)

February 23, 2026

Last Update Submitted That Met QC Criteria

February 19, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • TELERIABPTA

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Telerehabilitation

Clinical Trials on Telerehabilitation

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in India

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe